Cargando…

Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front

Reduction of epithelial cell–cell adhesion via the transcriptional repression of cadherins in combination with the acquisition of mesenchymal properties are key determinants of epithelial–mesenchymal transition (EMT). EMT is associated with early stages of carcinogenesis, cancer invasion and recurre...

Descripción completa

Detalles Bibliográficos
Autores principales: De Wever, Olivier, Pauwels, Patrick, De Craene, Bram, Sabbah, Michèle, Emami, Shahin, Redeuilh, Gérard, Gespach, Christian, Bracke, Marc, Berx, Geert
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2522326/
https://www.ncbi.nlm.nih.gov/pubmed/18648847
http://dx.doi.org/10.1007/s00418-008-0464-1
_version_ 1782158650827079680
author De Wever, Olivier
Pauwels, Patrick
De Craene, Bram
Sabbah, Michèle
Emami, Shahin
Redeuilh, Gérard
Gespach, Christian
Bracke, Marc
Berx, Geert
author_facet De Wever, Olivier
Pauwels, Patrick
De Craene, Bram
Sabbah, Michèle
Emami, Shahin
Redeuilh, Gérard
Gespach, Christian
Bracke, Marc
Berx, Geert
author_sort De Wever, Olivier
collection PubMed
description Reduction of epithelial cell–cell adhesion via the transcriptional repression of cadherins in combination with the acquisition of mesenchymal properties are key determinants of epithelial–mesenchymal transition (EMT). EMT is associated with early stages of carcinogenesis, cancer invasion and recurrence. Furthermore, the tumor stroma dictates EMT through intensive bidirectional communication. The pathological analysis of EMT signatures is critically, especially to determine the presence of cancer cells at the resection margins of a tumor. When diffusion barriers disappear, EMT markers may be detected in sera from cancer patients. The detection of EMT signatures is not only important for diagnosis but can also be exploited to enhance classical chemotherapy treatments. In conclusion, further detailed understanding of the contextual cues and molecular mediators that control EMT will be required in order to develop diagnostic tools and small molecule inhibitors with potential clinical implications.
format Text
id pubmed-2522326
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-25223262008-08-27 Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front De Wever, Olivier Pauwels, Patrick De Craene, Bram Sabbah, Michèle Emami, Shahin Redeuilh, Gérard Gespach, Christian Bracke, Marc Berx, Geert Histochem Cell Biol Review Reduction of epithelial cell–cell adhesion via the transcriptional repression of cadherins in combination with the acquisition of mesenchymal properties are key determinants of epithelial–mesenchymal transition (EMT). EMT is associated with early stages of carcinogenesis, cancer invasion and recurrence. Furthermore, the tumor stroma dictates EMT through intensive bidirectional communication. The pathological analysis of EMT signatures is critically, especially to determine the presence of cancer cells at the resection margins of a tumor. When diffusion barriers disappear, EMT markers may be detected in sera from cancer patients. The detection of EMT signatures is not only important for diagnosis but can also be exploited to enhance classical chemotherapy treatments. In conclusion, further detailed understanding of the contextual cues and molecular mediators that control EMT will be required in order to develop diagnostic tools and small molecule inhibitors with potential clinical implications. Springer-Verlag 2008-07-22 2008-09 /pmc/articles/PMC2522326/ /pubmed/18648847 http://dx.doi.org/10.1007/s00418-008-0464-1 Text en © Springer-Verlag 2008
spellingShingle Review
De Wever, Olivier
Pauwels, Patrick
De Craene, Bram
Sabbah, Michèle
Emami, Shahin
Redeuilh, Gérard
Gespach, Christian
Bracke, Marc
Berx, Geert
Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front
title Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front
title_full Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front
title_fullStr Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front
title_full_unstemmed Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front
title_short Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front
title_sort molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2522326/
https://www.ncbi.nlm.nih.gov/pubmed/18648847
http://dx.doi.org/10.1007/s00418-008-0464-1
work_keys_str_mv AT deweverolivier molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront
AT pauwelspatrick molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront
AT decraenebram molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront
AT sabbahmichele molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront
AT emamishahin molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront
AT redeuilhgerard molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront
AT gespachchristian molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront
AT brackemarc molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront
AT berxgeert molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront